NewMed Energy is an Israel-based upstream oil and gas partnership focused on exploration, development, and production in the Eastern Mediterranean. Formerly known as Delek Drilling, the partnership adopted the NewMed Energy name in 2022 and is listed on the Tel Aviv Stock Exchange.
NewMed holds significant interests in the Leviathan natural gas field offshore Israel and a stake in the Aphrodite field offshore Cyprus, working alongside international partners including Chevron and Shell. Its activities center on supplying natural gas to domestic and regional markets and supporting export routes, including pipeline deliveries and connections to liquefaction infrastructure in Egypt. The partnership continues to pursue additional exploration and development opportunities across the region.
Also known as Delek Drilling.
35% non-operated stake in Cyprus Block 12 (Aphrodite); produced gas to be sold to EGAS; completion expected early 2027, subject to approvals.
Record investments of 7.8 bn lei amid market volatility; net income down 27% due to impairments; strategic focus on energy transition and regional gas growth.
BEH acquires 10% in Han Asparuh offshore venture. Exploration drilling began in Dec 2025. Potential economic benefits include GDP growth and enhanced energy security for Bulgaria.
Leviathan's gas capacity to increase to 21 BCM annually, boosting energy supply for Israel, Egypt, and Jordan. Completion expected by decade's end.
Exploration drilling in Bulgaria's Han Asparuh block starts with two wells, costing €170M, using advanced tech and safety standards, aiming to enhance regional energy security.
